Lindsey Zubritsky
AuthID: R-00F-CMG
1
TITLE: Elevated pretreatment serum activin A and progression-free and overall survival in trastuzumab-treated metastatic breast cancer.
AUTHORS: Allan Lipton; Lindsey Zubritsky; Kim Leitzel; Suhail M Ali; Wolfgang Koestler; Eva Maria Fuchs; Luis Costa; Robert D Knight; Abderrahmane Laadem; Matthew L Sherman;
PUBLISHED: 2012, SOURCE: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, ISSUE: 15
AUTHORS: Allan Lipton; Lindsey Zubritsky; Kim Leitzel; Suhail M Ali; Wolfgang Koestler; Eva Maria Fuchs; Luis Costa; Robert D Knight; Abderrahmane Laadem; Matthew L Sherman;
PUBLISHED: 2012, SOURCE: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, ISSUE: 15
INDEXED IN: 
WOS
WOS2
TITLE: Elevated pretreatment serum activin A and progression-free and overall survival in trastuzumab-treated metastatic breast cancer
AUTHORS: Lindsey Zubritsky; Kim Leitzel; Suhail M Ali; Wolfgang Kstler; Eva Maria Fuchs; Luis Costa; Robert D Knight; Abderrahmane Laadem; Matthew L Sherman; Allan Lipton;
PUBLISHED: 2012, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, ISSUE: 30
AUTHORS: Lindsey Zubritsky; Kim Leitzel; Suhail M Ali; Wolfgang Kstler; Eva Maria Fuchs; Luis Costa; Robert D Knight; Abderrahmane Laadem; Matthew L Sherman; Allan Lipton;
PUBLISHED: 2012, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, ISSUE: 30
INDEXED IN: WOS
WOS